(MLTX) MoonLake - Performance -15% in 12m
Compare MLTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
55.02%
#10 in Group
Rel. Strength
33.21%
#5343 in Universe
Total Return 12m
-15.01%
#53 in Group
Total Return 5y
252.43%
#10 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -26.28%
(?) Percentile in Group
12m Total Return: MLTX (-15%) vs XBI (-12.1%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: MLTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MLTX
Total Return (including Dividends) | MLTX | XBI | S&P 500 |
---|---|---|---|
1 Month | -4.40% | -14.90% | -7.04% |
3 Months | -10.85% | -14.51% | -10.88% |
12 Months | -15.01% | -12.11% | 5.72% |
5 Years | 252.43% | -20.56% | 100.77% |
Trend Score (consistency of price movement) | MLTX | XBI | S&P 500 |
1 Month | -84.3% | -85.2% | -76.1% |
3 Months | -90.7% | -87.6% | -86.4% |
12 Months | 0.30% | -24% | 67.8% |
5 Years | 68.4% | -52.8% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #44 | 12.3% | 2.84% |
3 Month | #57 | 4.28% | 0.04% |
12 Month | #53 | -3.30% | -19.6% |
5 Years | #7 | 446% | 116% |
FAQs
Does MLTX MoonLake outperforms the market?
No,
over the last 12 months MLTX made -15.01%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months MLTX made -10.85%, while XBI made -14.51%.
Over the last 3 months MLTX made -10.85%, while XBI made -14.51%.
Performance Comparison MLTX vs Indeces and Sectors
MLTX vs. Indices MLTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 6.94% | 2.64% | -15.6% | -20.7% |
US NASDAQ 100 | QQQ | 7.43% | 3.46% | -15.5% | -18.7% |
US Dow Jones Industrial 30 | DIA | 5.04% | 0.77% | -17.6% | -21.7% |
German DAX 40 | DAX | -5.56% | 3.65% | -34.2% | -34.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.06% | 3.35% | -20.4% | -23.0% |
Hongkong Hang Seng | HSI | -0.73% | 6.75% | -17.0% | -31.2% |
India NIFTY 50 | INDA | 2.93% | -7.82% | -15.0% | -15.7% |
Brasil Bovespa | EWZ | 2.43% | 1.88% | -15.9% | -4.08% |
MLTX vs. Sectors MLTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.13% | 3.18% | -23.8% | -28.3% |
Consumer Discretionary | XLY | 8.53% | 1.82% | -17.8% | -22.4% |
Consumer Staples | XLP | 1.68% | -4.29% | -23.2% | -27.5% |
Energy | XLE | 5.98% | 7.52% | -14.5% | -2.21% |
Financial | XLF | 4.23% | 0.47% | -23.5% | -34.4% |
Health Care | XLV | 4.53% | 2.38% | -14.4% | -14.9% |
Industrial | XLI | 4.44% | 1.57% | -15.0% | -18.9% |
Materials | XLB | 3.44% | 3.04% | -8.17% | -7.07% |
Real Estate | XLRE | 1.19% | 0.59% | -15.3% | -29.4% |
Technology | XLK | 7.63% | 5.43% | -9.56% | -11.8% |
Utilities | XLU | 1.42% | -2.29% | -19.8% | -41.4% |
Aerospace & Defense | XAR | 2.28% | -3.79% | -25.0% | -38.2% |
Biotech | XBI | 2.42% | 10.5% | 0.31% | -2.90% |
Homebuilder | XHB | 7.55% | 4.81% | 3.83% | -3.32% |
Retail | XRT | 7.18% | 1.35% | -8.30% | -7.99% |